Clinical Trial Detail

NCT ID NCT03466294
Title Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Age Groups: adult senior

No variant requirements are available.